The number most people skip

In the methods section of this abstract there are two concentrations:

  • Hydrogen sulfide: 10 micromolar
  • SS-31: 10 nanomolar

They look almost the same at a glance. Ten and ten. But micro and nano are not the same thing at all.

A micromolar is a thousand times more than a nanomolar. So the SS-31 concentration was one thousand times lower than the hydrogen sulfide concentration.

And yet, in Part 5, both raised HSP70 to almost exactly the same level.

What a concentration means

When researchers talk about molar concentrations, they are describing how many molecules of a substance are in a given volume of liquid.

You do not need the chemistry to get the point. Ten nanomolar is a very small amount. It is the kind of concentration associated with compounds that act on a precise target, rather than ones that need to flood the cell to have an effect.

Why SS-31 can work at such low levels

The other papers in this collection help explain this.

SS-31 is designed to find its target. It gets into cells and concentrates at the inner membrane of mitochondria, drawn there by the electrical charge mitochondria hold across that membrane. It binds to cardiolipin, a fat found almost only in mitochondria.

A compound that concentrates itself at its target does not need to be present at high levels in the surrounding fluid. The cell does part of the work by pulling it to where it is needed. That is one reasonable explanation for why a tiny amount in the dish could still have a strong effect inside the cells.

The developer at the bench

As noted in Part 1, Hazel Szeto is a co-author on this abstract, and she is one of the scientists behind the SS peptide family. Her lab would have known the concentration range where SS-31 is likely to act from earlier work.

That is useful context. The choice of 10 nanomolar was probably not a guess. It likely reflects experience with how the peptide behaves in cells.

It is also something to keep in mind when weighing the results, as we will discuss in the final part. Researchers who developed a compound naturally have an interest in it. That does not make their findings wrong, but it is worth knowing.

A link to the Wisconsin study

Here is a connection I find genuinely interesting.

In the Wisconsin study, covered in another series, SS-31 was tested across a range from 0.01 to 10 micromolar. The lowest concentration, 0.01 micromolar, is exactly the same as 10 nanomolar.

And in that study, it was the lowest concentration that produced the clearest individual effect on BAX: the gathering phase lasted on average 9.6 minutes longer than in untreated cells, a significant difference. The higher concentrations did not show a clear individual effect.

Two different labs, two different cell types, ten years apart, and 10 nanomolar shows up as an active concentration in both. That does not prove anything on its own, but it is the kind of consistency that makes a result more believable.

More is not always more

This also echoes the dose result from the brain bleed series. There, a middle dose of SS-31 worked best, and doubling it did not add benefit.

Here, a very low concentration of SS-31 produced the same HSP70 effect as a much higher concentration of a different compound. And in the Wisconsin study, the lowest concentration stood out.

Across all three, a theme emerges. With SS-31, more does not seem to mean better. Effects appear at modest levels and do not necessarily grow with higher amounts.

That pattern is common with compounds that act on a specific target. Once the target is occupied, adding more does little except raise the chance of unwanted effects elsewhere.

A firm caution

None of this translates into a human dose. A concentration in a dish of muscle cells tells you about how cells respond in a controlled environment. It says nothing about how much would reach muscle tissue in a living body, how quickly it would be cleared, or what amount would be safe.

The point of this part is not the number itself. It is what the number reveals about the compound: SS-31 behaves like a precise, targeted molecule that does not need large amounts to have an effect in cells.

Next, in the final part of this series, I look at what a one-page abstract can and cannot tell us, and why that matters before anyone builds a claim on it.

This series discusses a published conference abstract describing a laboratory study in cultured mouse cells. The results have not been shown in people. Nothing here is medical advice, and SS-31 is discussed for research purposes only.